Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA)

Innate Pharma S.A. is a clinical-stage biotechnology company dedicated to improving cancer treatment and clinical outcomes for patients through first-in-class therapeutic antibodies that harness the innate immunity. Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body’s immune system to recognize and kill cancer cells. The Company’s broad pipeline includes four first-in-class clinical stage antibodies as well as preclinical candidates and technologies that have the potential to address a broad range of cancer indications with high unmet medical needs. Innate Pharma has pioneered the discovery and development of checkpoint inhibitors, with a unique expertise and understanding of Natural Killer cell biology. This innovative approach has resulted in major alliances with leaders in the biopharmaceutical industry including AstraZeneca, Bristol-Myers Squibb, Novo Nordisk A/S and Sanofi. Innate Pharma is building the foundations to become a fully-integrated biopharmaceutical company. Based in Marseille, France, Innate Pharma has more than 180 employees and is listed on Euronext Paris. *


Period Start 1999-01-01 established
Products Industry BIOTECH
  Industry 2 cancer immunotherapy (immuno-oncology, I-O)
Person Person Brailly, Hervé (Innate Pharma 201612– Chairman of Supervisory Board before CEO + Co-Founder)
Region Region Marseille
  Country France
  Street 117 avenue de Luminy
  City 13276 Marseille
  Tel +33-4-30303030
    Address record changed: 2020-12-02
Basic data Employees D: 101 to 500 (2018-12-31)
  Currency EUR
  Annual sales 93,952,000 (revenue, operating (2018) 2018-12-31)
  Profit 3,049,000 (2018-12-31)
  Cash 152,314,000 (2018-12-31)
    * Document for �About Section�: Innate Pharma S.A.. (1/31/18). "Press Release: Prof. Jean-Yves Blay Appointed to the Innate Pharma Supervisory Board". Marseille.
Record changed: 2020-06-26


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top